Currently, marijuana shares Schedule 1 status with heroin, and is strictly regulated. This post from Washington Times reports 2016 Libertarian White House hopeful Gary Johnson saying that he thinks President Obama will reschedule marijuana on his way out of office. Former New Mexico Gov. and 2016 Libertarian White House hopeful Gary Johnson says he thinks President Obama is ... Continue Reading
LSD
STUDY: Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light
ABSTRACT: The prevalent view today is that schizophrenia is a syndrome rather than a specific disease. Liability to schizophrenia is highly heritable. It appears that multiple genetic and environmental factors operate together to push individuals over a threshold into expressing the characteristic clinical picture. One environmental factor which has been curiously neglected ... Continue Reading
Oliver Sacks Explored the Brain with Legal LSD—Before Drug War
LSD helped Dr. Oliver Sacks be more empathic. It was legal then. Is the Drug War standing in the way of researching therapeutic benefits of psychedelics? This post from Drug Policy Alliance revisits the impact of drug war on drug education and research. What if Oliver Sacks had been born 20 years later? Would he have been able to explore new avenues of neurochemical and ... Continue Reading
DEA Agrees Marijuana Safer Than Heroin
Even though marijuana is still classified alongside heroin and LSD as a schedule 1 drug, DEA seems to be shifting its stand, just slightly, on marijuana. This post from TIME reports how the new DEA chief has finally admitted what people have known for years. The DEA chief had said pot is "probably not" as bad as heroin, but that he was "not an expert" The head of the ... Continue Reading
STUDY: Drug models of schizophrenia
ABSTRACT: Schizophrenia is a complex mental health disorder with positive, negative and cognitive symptom domains. Approximately one third of patients are resistant to currently available medication. New therapeutic targets and a better understanding of the basic biological processes that drive pathogenesis are needed in order to develop therapies that will improve quality ... Continue Reading